National Planning Corporation’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

National Planning Corporation’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-19,583	Closed	-$18K	–	756
2015 Q4	$18K	Buy	+19,583	New	+$31.5K	﹤0.01%	722
2015 Q1	–	Sell	-21,650	Closed	-$37K	–	2550
2014 Q4	$37K	Sell	21,650 -222	-1%	-$193	﹤0.01%	1424
2014 Q3	$16K	Sell	21,872 -378	-2%	-$681	﹤0.01%	745
2014 Q2	$50K	Sell	22,250 -850	-4%	-$2.11K	﹤0.01%	745
2014 Q1	$74K	Buy	23,100 +2,075	+10%	+$6.83K	0.01%	702
2013 Q4	$66K	Sell	21,025 -50	-0.2%	-$139	0.01%	693
2013 Q3	$63K	Buy	+21,075	New	+$57.1K	0.01%	653

Other funds holding ECTE

Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

National Planning Corporation's ECTE Position: Q1 2016 in Review

National Planning Corporation sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q1 2016, closing a stake of 19,583 shares — an estimated $18K sold.

National Planning Corporation first reported a position in ECTE in Q3 2013 and held it in 7 quarters. The position peaked at $74K in Q1 2014. 15 funds tracked by Wall St. Rank hold ECTE as of Q1 2016.

National Planning Corporation reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q1 2016 after selling out during the quarter.
National Planning Corporation sold 19,583 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q1 2016, an estimated $18K.
National Planning Corporation first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q3 2013 and held it in 7 quarters.
National Planning Corporation's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $74K in Q1 2014.
15 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q1 2016.

Based on National Planning Corporation's 13F filing for Q1 2016, filed 16 May 2016.